# Substance Use Disorder in Myanmar

## Commonly Used Drugs in Myanmar

- **`Heroin`**: Most prevalent, often injected.
- **`Methamphetamine`**: Known locally as "yaba," commonly used for its stimulant effects.
- **`Cannabis`**: Used recreationally.
- **`Opium`**: Traditional use in some areas.
- **Prescription medications**: Misuse of `opioids`, `benzodiazepines`, and other medications.

## Diagnosis Criteria

### DSM-5 Criteria for Substance Use Disorder

A problematic pattern of substance use leading to significant impairment or distress, manifested by at least two of the following within a 12-month period:

1. Substance taken in larger amounts or over a longer period than intended.
2. Persistent desire or unsuccessful efforts to cut down or control use.
3. A great deal of time spent in activities necessary to obtain, use, or recover from the substance's effects.
4. Craving, or a strong desire or urge to use the substance.
5. Recurrent use resulting in a failure to fulfill major role obligations.
6. Continued use despite having persistent or recurrent social or interpersonal problems.
7. Important social, occupational, or recreational activities given up or reduced.
8. Recurrent use in situations where it is physically hazardous.
9. Use is continued despite knowledge of having a persistent or recurrent physical or psychological problem.
10. Tolerance.
11. Withdrawal.

## Consequences of Injection Drug Use (People Who Inject Drugs - PWID)

- **Infectious diseases**: HIV, Hepatitis B and C.
- **Bacterial infections**: Abscesses, endocarditis, cellulitis.
- **Vein damage**: Collapsed veins, thrombophlebitis.
- **Overdose**: Increased risk due to the unknown purity of drugs.
- **Social consequences**: Stigmatization, legal issues, and relationship problems.

## Opiate Withdrawal Features

- **Early Symptoms**:
  - Anxiety
  - Agitation
  - Muscle aches
  - Increased tearing
  - Insomnia
  - Runny nose
  - Sweating
  - Yawning
- **Late Symptoms**:
  - Abdominal cramping
  - Diarrhea
  - Dilated pupils
  - Goosebumps
  - Nausea and vomiting

## Clinical Features of Opiate Overdose

- **Central Nervous System**:
  - Reduced level of consciousness or unresponsiveness.
  - Coma.
- **Respiratory**:
  - Slow, shallow breathing (respiratory depression).
  - Cyanosis (bluish discoloration of skin due to low oxygen).
- **Cardiovascular**:
  - Hypotension (low blood pressure).
  - Bradycardia (slow heart rate).
- **Other Signs**:
  - Pinpoint pupils (miosis).
  - Pulmonary edema (fluid in the lungs).

## Amphetamine-Type Stimulant (ATS) Abuse

### Central Features of ATS Abuse

- **Euphoria**: Intense feelings of pleasure and well-being.
- **Increased energy**: Hyperactivity and reduced need for sleep.
- **Alertness**: Heightened attention and concentration.
- **Aggression**: Increased irritability and aggression.
- **Paranoia**: Delusions and suspicion without basis.
- **Hallucinations**: Seeing or hearing things that are not there.
- **Psychomotor agitation**: Restlessness and excessive movement.

### Withdrawal Features of ATS Abuse

- **Fatigue**: Profound tiredness and lack of energy.
- **Depression**: Low mood, anhedonia (inability to feel pleasure), and dysphoria (general dissatisfaction).
- **Increased appetite**: Weight gain and strong cravings for food.
- **Sleep disturbances**: Insomnia or hypersomnia (excessive sleep).
- **Anxiety**: Heightened nervousness and worry.
- **Irritability**: Easily annoyed or angered.
- **Cognitive deficits**: Impaired concentration and memory.

### Long-term Effects of ATS Abuse

- **Psychiatric disorders**:
  - Persistent psychosis.
  - Chronic anxiety and depression.
  - Cognitive impairments (memory loss, decreased attention span).
- **Cardiovascular problems**:
  - Hypertension (high blood pressure).
  - Tachycardia (fast heart rate).
  - Increased risk of stroke and heart attack.
- **Neurological damage**:
  - Neurotoxicity (damage to brain cells).
  - Increased risk of Parkinsonâ€™s disease.
- **Dental issues**:
  - Severe tooth decay and gum disease (commonly known as "meth mouth").
- **Weight loss and malnutrition**: Due to reduced appetite and poor dietary habits.
- **Infectious diseases**: Higher risk due to compromised immune system and risky behaviors.
- **Social consequences**:
  - Relationship problems.
  - Employment issues.
  - Legal troubles.

## Management of Substance Use Disorder

### General Management Principles

1. **Assessment and Diagnosis**:

   - Comprehensive medical, psychiatric, and social history.
   - Physical examination.
   - Screening for co-occurring mental health disorders and infectious diseases.
   - Use of diagnostic criteria (e.g., DSM-5) to confirm substance use disorder.

2. **Detoxification**:

   - Medically supervised detoxification for substances with significant withdrawal risks (e.g., `alcohol`, `opioids`, `benzodiazepines`).
   - Use of withdrawal management medications (e.g., `benzodiazepines` for alcohol withdrawal, `methadone` or `buprenorphine` for opioid withdrawal).

3. **Pharmacological Treatment**:

   - **Alcohol Use Disorder**:
     - `Disulfiram` (Antabuse): Produces unpleasant effects when alcohol is consumed.
     - `Naltrexone` (ReVia, Vivitrol): Reduces cravings and the rewarding effects of alcohol.
     - `Acamprosate` (Campral): Reduces withdrawal symptoms and cravings.
   - **Opioid Use Disorder**:
     - `Methadone`: Full opioid agonist used in maintenance therapy.
     - `Buprenorphine`: Partial opioid agonist used in maintenance therapy.
     - `Naltrexone`: Opioid antagonist that blocks the effects of opioids.
   - **Tobacco Use Disorder**:
     - Nicotine replacement therapy (patches, gums, lozenges).
     - `Bupropion` (Zyban): Reduces cravings and withdrawal symptoms.
     - `Varenicline` (Chantix): Reduces cravings and withdrawal symptoms.

4. **Behavioral and Psychosocial Interventions**:

   - **Cognitive-Behavioral Therapy (CBT)**: To address maladaptive thought patterns and behaviors related to substance use.
   - **Motivational Interviewing (MI)**: Enhancing motivation to change and engage in treatment.
   - **Contingency Management (CM)**: Using incentives to reinforce positive behaviors.
   - **12-Step Programs**: Support groups such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA).
   - **Family Therapy**: Involving family members in the treatment process.

5. **Supportive Care**:

   - Nutritional support and hydration.
   - Education on healthy lifestyle choices and stress management.
   - Sleep hygiene education.

6. **Treatment of Co-Occurring Disorders**:

   - Integrated treatment for individuals with dual diagnoses (e.g., depression, anxiety, PTSD).
   - Appropriate use of psychiatric medications.

7. **Harm Reduction Strategies**:

   - Needle exchange programs.
   - Safe consumption spaces.
   - Access to naloxone for opioid overdose prevention.
   - Education on safer use practices.

8. **Relapse Prevention and Aftercare**:

   - Regular follow-up appointments and monitoring.
   - Ongoing counseling and support groups.
   - Development of a relapse prevention plan, including identification of triggers and coping strategies.

9. **Rehabilitation and Social Support**:
   - Assistance with housing, employment, and legal issues.
   - Vocational training and rehabilitation programs.
   - Encouragement to engage in healthy recreational activities and community involvement.
